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ABSTRACT: Phospholipids are at the heart and origin of life on this planet. The possibilities in terms of phospholipid self-
assembly and biological functions seem limitless. Nonetheless, nature exploits only a small fraction of the available chemical
space of phospholipids. Using chemical synthesis, artiﬁcial phospholipid structures become accessible, and the study of their
biophysics may reveal unprecedented properties. In this article, the recent advances by our work group in the ﬁeld of chemical
lipidology are summarized. The family of diamidophospholipids is discussed in detail from monolayer characterization to the
formation of faceted vesicles, culminating in the template-free self-assembly of phospholipid cubes and the possible applications
of vesicle origami in modern personalized medicine.
■ INTRODUCTION
Phospholipids are life-enabling molecules. Over the millennia,
nature has created this class of amphiphilic molecules to help
bridge interfaces such as the interior and exterior of a cell.1 In
recent years, it has been more and more appreciated that the
phospholipids are not merely limited to a passive amphiphilic
role2 but are actively involved in human metabolism.3
Seemingly small changes in the chemical structure of a
phospholipid may decide the life or death of an organism, such
as the end functionalization of a long fatty acyl chain from
straight to iso-branched.4 The study of such structural changes
requires the convergence5 of chemical synthesis and the
biochemical and biophysical characterization of phospholi-
pids.6 Lipidomics discovers natural phospholipids. The ﬁeld
that forages for nonnatural phospholipids we have termed
chemical lipidology. The chemical space to be explored is
nearly inﬁnite, and chemical lipidology has the potential to
discover unprecedented approaches to nanomedicial applica-
tions. In this feature article, I have therefore highlighted several
recent examples of chemical lipidology from our work group,
expanding on research that began 10 years ago.7
■ DIFFERENT PARTS OF A PHOSPHOLIPID
Chemically speaking, a phospholipid is made from four
diﬀerent parts (Figure 1): two fatty acyl chains, a
phosphorylated headgroup, and a backbone holding everything
together. Each of these four parts can be chemically modiﬁed,
so the possibilities of putting together new types of
phospholipid molecules are nearly endless.7,8 In recent
decades, the convenience of commercially available phospho-
lipids led to a decrease in the types of phospholipids studied.
This was not always the case, and the 1970s and 1980s saw a
variety of groups working in the ﬁeld of chemical lipidology.
The medicinal aspects were important from the beginning, and
ways to inhibit the enzyme phospholipase A2 were sought.
9
Phospholipase A2 is involved in the homeoviscous adaptation
of phospholipids, the cleavage of fatty acids, and the
attachment of other fatty acids in order to adapt the cell
Figure 1. Glycerophospholipids are modular structures made from
four building blocks: two fatty acyl chains, a phosphorylated
headgroup, and a backbone holding everything together.
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membrane to external conditions.10 Later, the secretory
phospholipase A2 of cancer cells was used to cleave an
anticancer prodrug chemically attached to the sn-2 position of
a phospholipid.11 Artiﬁcial phospholipids were also tested as
anti-AIDS drugs, but with limited success.12 And one should
not forget a series of great minds working on stabilizing
liposomes using diacetylene-type phospholipids.13,14
■ PHOSPHOLIPID NOMENCLATURE
Given the modularity of the phospholipids, there are a nearly
inﬁnite number of possible structures that are accessible.
Already >43 000 natural structures are known, and with the
advent of lipidomics,15 the Lipid MAPS project started its
important work of collecting and curating all data and mapping
the lipids using a 12-digit identiﬁer code.3,16
The standard phospholipid nomenclature has been intro-
duced by the International Union of Pure an Applied
Chemistry and is based on the Fischer projection of the
phospholipid’s glycerol backbone.17 The fatty acyl chain on the
secondary alcohol is brought into an L position. The
numbering of the glycerol carbon centers from top (1) to
bottom (3) leads to stereospeciﬁc nomenclature (sn) and
names such as 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-
choline (POPC) and 3-palmitoyl-2-oleoyl-sn-glcero-1-phos-
phocholine for its enantiomer. As we advanced into unknown
phospholipid territory, we found that we needed a mapping
system to classify the new compounds in a non-machine-coded
way and we needed a nomenclature that would put more
weight on the nature of the chemical bonds between fatty acyl
chains and the lipid backbone. Therefore, we adopted and
expanded a modular nomenclature that had been introduced
earlier by Szoka et al.18,19 The standard abbreviation for the
headgroups (PC for phosphocholine) and fatty acyl chains (P
for palmitoyl and O for oleoyl) were retained, and two letters
would be used to unambiguously identify the chemical linker
used to connect the fatty acyl chains to the backbone: “es”
would be an ester; “et”, an ether; “ad”, an amide; and “ur”, a
urea. The standard POPC would therefore become Pes-Oes-
PC, and its enantiomer, PC-Oes-Pes. The nomenclature allows
us to understand how many unexplored lipid classes exist and
how structurally limited nature essentially is. We were then
able to move from natural phospholipids Xes-Xes-PC (X
stands for any chain length and saturation/unsaturation) and
Xet-Xet-PC into unknown lipids such as Xad-Xad-PC, Xad-
PC-Xad, and Xur-PC-Xur, which will all be covered in this
feature article.
■ PHOSPHOLIPID ASSEMBLIES AND WAYS TO
STUDY THEM
In nature, phospholipids are not found as individual molecules
but rather are found in diﬀerent types of ensembles. Because of
the presence of two fatty acyl chains in one molecule, the
phospholipids aggregate at very low concentrations. For DPPC
(1, see Figure 2), the critical value lies at 0.46 nM at 20 °C.20
As a comparison, the single C16 chain lysoPC aggregates only
at a 4 orders of magnitude higher concentration of 8.3 μM.20
The many possibilities in which phospholipids can associate
lead to a broad spectrum of analytical methods that can be
used for phospholipid characterization.
Typically, phospholipids in nature are found in bilayer
arrangements. However, it is possible to study artiﬁcial
monolayers of phospholipids.21 This has the big advantage of
separating forces that are present in one membrane leaﬂet from
forces present in a lipid bilayer.22 At an air/water interface,
phospholipids spread into ﬁlms that are one molecule thick.
These ﬁlms can be laterally compressed by a barrier, and the
measured change in surface pressure certainly is one of the
oldest ways to study ensembles of phospholipids.23 In the late
1980s and 1990s, powerful new techniques became available
that enabled the probe-free (recently, a new push−pull
pressure-sensitive ﬂuorophore was introduced that does not
change the organization of phospholipids,24 along with a
multiparametric sensing ﬂuorescent probe25) study of the
deeper structure of monolayers using synchrotron X-ray
diﬀraction,26,27 X-ray reﬂectivity,28 FTIR reﬂection absorption
spectroscopy,29,30 specular reﬂections of neutrons,31 and
Brewster angle microscopy.32,33 In particular, the X-ray
scattering of phospholipid monolayers is now well under-
stood,34 and beamlines such as the P08 of PETRA III of the
Deutsches Synchrotron (DESY) allow routine measurements
of lipid monolayers. In combination with the latest MatLab
scripts,35 it is possible to analyze the results immediately after a
measurement, which allows us to retake measurements make
with faulty monolayer ﬁlms.35
Various ways exist to formulate phospholipids into lip-
osomes (or vesicles), uni- or multilamellar bilayers surrounding
a water-ﬁlled core.36 Interestingly, for drug-delivery purposes
drug molecules can be incorporated into the aqueous core or
the membranes of liposomes. The drug should stay trapped
Figure 2. Chemical structures of the lipids discussed in this article.
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inside the vesicle for a prolonged time. This depends on
various factors, not the least important of which is the main
phase-transition temperature of the bilayer. At and above this
temperature, the phospholipid fatty acyl hydrocarbon chains
have enough energy to change from an antiperiplanar (all-
trans) conformation to a higher-energy conformation contain-
ing gauche interactions.37 This cooperative change in the
phospholipid tails38 can be studied using diﬀerential scanning
calorimetry and leads to a phase change from a gel phase to a
liquid-crystalline phase, concomitant with the rapid release of
the vesicle-entrapped cargo at and above the main phase-
transition temperature.38,39
Unfortunately, the typical large unilamellar vesicles used for
drug delivery are around 100 nm in diameter, so they are too
small for optical characterization using even super-resolution
microscopy. Here, cryogenic transition electron microscopy
(cryo-TEM) helps us to obtain single snapshots of frozen
vesicles.40 The geometrical factors determined from cryo-TEM
images and size values measured with dynamic light scattering
(DLS) can be used as starting values for ﬁtting small-angle
neutron scattering data.41,42 Together with small- and wide-
angle X-ray spectroscopy measurements,43 a statistically
correct picture of the true vesicle population properties
emerges.
■ PHOSPHOLIPID SYNTHESIS
The chemical space of artiﬁcial phospholipids is immense, but
each new lipid obviously ﬁrst needs to be created through
chemical synthesis before any biophysical testing may begin.
Unfortunately, synthesizing phospholipids is much harder than
it looks on paper.44 Working with amphiphilic molecules
requires special polar solvent mixtures, and standard laboratory
techniques such as liquid/liquid extraction cannot be used.
Fortunately, there is already a vast body of literature on natural
and artiﬁcial phospholipid synthesis that would ﬁll its own
review article.6,14,45−52
Early lecithin synthesis in the 1920s was rather straightfor-
ward, and as part of the procedure, glycerol 1,2-distearate,
phosphoric acid anhydride, and choline bicarbonate were
vigorously kneaded for 4 min and the product was then
extracted with almost-boiling benzene.44 Luckily, more
sophisticated and less hands-on methods became available in
the meantime. Nowadays, a handful of reagents exist that are
useful for the synthesis of phospholipids, but unfortunately,
many of them come at a prohibitively high cost because they
are also used in polynucleotide synthesis.8,53 There is always a
thin reactivity line between the (too) reactive P(III) reagents
and the less-reactive P(V) reagents. The propensity of P(III)
reagents to react twice with an alcohol is high, and unless
special reagents such as benzyloxydichlorophosphine53 are
used, the better option is usually P(V) reagents if
monosubstitution of the phosphate is desired. Over the
years, 2-bromoethyl phosphorodichloridate (12), the Hirt
reagent (Scheme 1), became a standard reagent for
phospholipid synthesis.54 The Hirt reagent allows the chemist
to introduce diﬀerent headgroups such as the standard ethyl
trimethylammonium group (14) or the ethyl dimethylam-
monium headgroups and more complex headgroups such as
ethyl N,N-dimethyl-N-(2-dimethylaminoethyl)ammonium.55,56
Out of the vast open chemical space of artiﬁcial
phospholipids we have chosen the genus of 1,3-diamidophos-
pholipids as a synthesis and biophysical challenge. In hindsight,
the choice turned out to be very lucky as this type of
phospholipid indeed possesses many interesting features that
will be discussed in this article.
A synthesis question arising early on is where to begin: at the
head or introducing the tails later or vice versa?8 For the class
of amido phospholipids, however, this question was easy to
answer: at the headgroup. This is due to the fact that amido
lipids without a phosphate headgroup are essentially
insoluble.57 Intermolecular hydrogen bonding between amide
groups leads to a β-sheet-like molecular arrangement. The
importance of this hydrogen bonding eﬀect showed up most
impressively when the melting points of the bis-esther Pes-
OH-Pes (72−73 °C) was compared to the melting point of
Pad-OH-Pad (10, 132−134 °C). Changing the molecular
structure from an ester (hydrogen bond acceptor) to an amide
(hydrogen bond donor and acceptor) led to an impressive
stabilization of the compounds with this 60 K increase in the
melting point.57 Synthesiswise it would be easy to add a
phosphate to Pad-OH-Pad (10), but this is impossible because
the reactant is insoluble. However, once a headgroup is
present, the formation of intermolecular hydrogen bonds is
hindered and the melting temperature again drops by 80 K.57
Overall, this shows that the interface between the fatty acyl
chains and the phosphate headgroup may have a large
inﬂuence on the interlipid forces. We have used this concept
when we have explored single-chain amphiphiles containing
various chemical moieties such as amides, ureas, and
thioureas.58 Interestingly, the thiourea moiety (9) leads to
the buildup of a very stiﬀ hydrogen bonding network between
the interface regions of single-chain amphiphiles. This network
was found to be self-healing and would reform itself after it was
destroyed at the air−water interface.58
Interphospholipid hydrogen bonds lead to a stabilization of
the vertical position between neighboring molecules. This has
a positive eﬀect on the polymerization behavior of the lipids.59
Typically, the diacetylene-substituted phospholipids can be
polymerized only when the molecules are preorganized in a gel
phase.13,14 Similarly, polyacetylene fatty acids preorganized at
an air/water interface readily polymerize into two-dimensional
carbon sheets.60 The system, however, is much more tolerable
to vertical misalignment when the polymerizable chemical
moieties are placed at the interface between the fatty acyl
chains and the polar headgroup.59 Liposomes formulated from
bis-acrylamido phospholipid (8) will easily polymerize into
liposomal superstructures.59 The liposomes may also be
admixed with nonpolymerizable lipids that can be washed
away after polymerization, leaving behind holey structures.
■ MONOLAYER PROPERTIES
Our research on the biophysical properties of 1,3-diamido-
phospholipids started out at the air/water interface of a
Langmuir/Pockels ﬁlm balance (Figure 3) with both C16 Pad-
PC-Pad (6) and its C18 homologue Sad-PC-Sad (7). Grazing
incidence-angle X-ray diﬀraction (GIXD) would give a
statistical average of the chain tilt angle and packing of the
phospholipids with their headgroups pointing into the water
Scheme 1. Synthesis of a Phosphocholine-Substituted
Alcohol Using the Hirt Reagent, 2-Bromoethyl
Phosphorodichloridate (12)
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phase and their fatty acyl chains pointing into the air. GIXD
signals are recorded only if there is indeed a global ordering of
the chains.34,61,62 This ordering does depend on the temper-
ature of the water subphase and on the compression of the
monolayer ﬁlm. For 35 mN/m and a 5 °C subphase
temperature, the two chains of Sad-PC-Sad are tilted by 18°.
Using a simple geometrical formula, the theoretical length of a
C−C alkyl chain in its all antiperiplanar (all-trans)
conformation can be calculated.63 For Sad-PC-Sad (7), this
would be 21.6 Å, and the corresponding height of this chain
tilted by 18° would be 20.5 Å. However, the actual thickness of
the lipid monolayer measured by X-ray reﬂectivity amounted
to 19.2 Å, a clear indication that not the entire fatty acyl chain
was in an all-antiperiplanar (all-trans) conformation and that
the methylene groups near the glycerol backbone were
disorganized (Figure 3).64 This disorganization at one end of
the acyl chains has consequences for shorter-chain C16 Pad-
PC-Pad (5): the overlap between the organized chains is not
long enough and van der Waals interactions between the
chains are not strong enough to keep the chains organized.
The tails try to overcompensate for this with a larger tilt of
31.5°, but the tilt is not oriented to a preferred direction
anymore and the chains are free to rotate.64 Such subtle
changes in chain−chain interactions will become important in
bilayers where Pad-PC-Pad (5) forms an interdigitated
membrane but Sad-PC-Sad (7) mostly fails to form vesicles.22
On a side note, one eﬀect is seen many times upon
prolonged monolayer compression: when a Sad-PC-Sad (7)
monolayer at 5 °C is kept for 2 h at a high lateral compression
of 35 mN/m, the tilt angle changes from 18 to 9° probably
because the intermolecular hydrogen bonds between the
headgroups are broken, giving more rotational freedom to the
chains and leading to a less-tilted state.
The power of the chemical synthesis of artiﬁcial
phospholipids lies in the possibility to probe the limits of
forces acting between molecules. Recently, we published the
properties of the 1,3-diureaphospholipid Sur-PC-Sur (11, see
Figure 3B), a molecule that contains two urea groups in the
backbone and is capable of donating and accepting two
hydrogen bonds per urea moiety.65 This lipid showed a
profound change in the lateral chain area upon prolonged
compression: The ﬁrst liquid condensed phase (LC1) was
dominated by intermolecular hydrogen bonding, spacing the
molecules widely apart and therefore forcing the tails into a
large 52° tilt. Upon further compression, the hydrogen bonds
were broken, the molecules were organized into a less ordered,
more densely packed condensed phase (LC2), and the tails
were again able to adopt a rotator phase with a much lower tilt
angle of 35°. Interestingly, the phase diagram for a Sur-PC-Sur
(11) monolayer shows two types of phase transitions, an
exothermic change (from liquid expanded to condensed) and
an endothermic change (between two condensed phases). This
means that upon compression of the monolayer the ﬁlm gets
more disorganized, which is certainly counterintuitive.65
■ BILAYER PROPERTIES
The question of if a phospholipid bilayer is simply the sum of
two monolayers is an interesting one. Ideally, a lipid monolayer
at the air/water interface represents half of the combined
forces in a bilayer membrane and typically both lipid
monolayers and bilayers do have the same main phase-
transition temperature, so the hypothesis is not far from
reality.37 Of course any biophysical study on model
phospholipids vastly underestimates the complexity of a
natural membrane, but already such simpler models hint at
additional forces being present in bilayers that are absent in
monolayers.66 One such obvious case is found when the two
leaﬂets of a bilayer membrane interdigitate.64,67,68
There is a tight correlation between the diﬀerent parts of a
phospholipid shown in Figure 1. Depending on the size of a
phospholipid headgroup compared to its tails, which is the
Israelachvili packing factor, phospholipids assemble into
diﬀerent superstructures when they are hydrated.69 Another
equally important factor is the orientation of the phospholipid
backbone in relation to the bilayer membrane normal. In a
standard 1,2-diacylglycerolipid such as DPPC (1), the
backbone is oriented parallel to the membrane normal.70
Exchanging the fatty acyl chains found in DPPC (1) for two
Figure 3. (A) Organization of a 1,3-diamidophospholipid at the air/water interface. The backbone forces the tails into a cone-shaped conformation.
(B) Surface pressure/molecular area isotherms for Sur-PC-Sur (11) at various subphase temperatures. The two condensed phases are indicated.
(A) Reprinted with permission from Fedotenko, L. A.; Stefaniu, C.; Brezesinski, G.; Zumbuehl, A. Monolayer Properties of 1,3-
Diamidophospholipids. Langmuir 2013, 29, 9428−9435. Copyright 2013 American Chemical Society. (B) Neuhaus, F.; Mueller, D.; Tanasescu,
R.; Stefaniu, C.; Zaﬀalon, P. L.; Balog, S.; Ishikawa, T.; Reiter, R.; Brezesinski, G.; Zumbuehl, A. Against the Rules: Pressure Induced Transition
from High to Reduced Order. Sof t Matter 2018, 14, 3978−3986. Reproduced by permission of The Royal Society of Chemistry.
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fatty alkyl chains gives 1,2-di-O-hexadecyl-sn-glycero-3-phos-
phocholine (DHPC, 3) with a glycerol that is oriented
perpendicularly to the bilayer normal.71,72 Similar to Sur-PC-
Sur (11), where breaking intermolecular hydrogen bonds
between phospholipid backbones leads to tighter packing, the
absence of carbonyl groups in DHPC (3) backbones73 leads to
a smaller area per hydrocarbon chain of Axy = 22.8 Å
2 due to
the closer chain packing.74 In diester phosphocholines, this
closer chain packing would be penalized by a reduction of the
freedom of the carbonyls to build up hydrogen bonds.75 The
diether phospholipid reacts to the tighter packing by forming a
fully interdigitated bilayer membrane75 in which one head-
group is essentially covering four alkyl chains.68 Recent
improvements in computational chemistry showed that
compared to DPPC (1), water penetrates deeper into DHPC
(3) bilayers, leading to an increase in the headgroup size, and
because of the better water organization, this leads to a
decrease in water permeability, making ether lipids ideal for use
in red blood cell and nerve myelin sheet membranes.76
Similar to DHPC (3), 1,3-diesterphospholipids (4) and 1,3-
diamidophospholipids (5) both have a backbone that is
oriented perpendicularly to the bilayer normal.77,78 This means
that the backbone dominates the Israelachvili packing factor
and deﬁnes the phospholipid geometry by spacing the two acyl
chains further apart compared to the spacing in a 1,2-
disubstituted phospholipid, leading to full bilayer membrane
interdigitation.78,79
That 1,3-diamidophospholipids form interdigitated mem-
branes was apparent from early comparisons of monolayer and
bilayer data. The 1,3-diamidophospholipids showed a bulk
main phase-transition temperature that was linearly increasing
with the length of the fatty acyl chains.64 However, the main
transition temperature did not correlate with the analogous
monolayer critical temperature at which a monolayer can no
longer be compressed into a condensed state. The critical
temperature for a 1,3-diamidophospholipid monolayer lies
almost 10 K below the main transition of the bilayer. This
shows that there are additional forces at play in a bilayer that
are not present in monolayers. The most probable force stems
from bilayer interdigitation. Additionally, the bilayer mem-
brane interdigitation can be estimated from cryo-TEM images
which for Rad-PC-Rad (6) has a very small value of 3.27 nm ±
0.14 nm.80 The interdigitation hypothesis was further
conﬁrmed by an electron density proﬁle calculated from X-
ray data of gel-phase vesicles.79
Interdigitation may be a naturally occurring phenomenon
when any biomembrane is stretched: the interdigitation
stabilizes the membrane laterally.81 Apart from this stretching
and the addition of small amphiphiles,82 interdigitation exists
only for gel-phase phospholipids. Above the main phase
transition, both 1,3-diesterphospholipids and 1,3-diamidophos-
pholipids deinterdigitate.78,79 This process is reversible, and
the membrane again interdigitates at temperatures below Tm.
The de-interdigitation can also be induced by adding as little as
10 mol % cholesterol.79 Cholesterol presumably ﬁlls the void
space between the two fatty acyl chains of a 1,3-diamidophos-
pholipid and so prevents the sliding-in of chains from the
opposite membrane leaﬂet.
Membrane interdigitation ﬁrmly connects the two leaﬂets of
a phospholipid bilayer. This leads to interesting phospholipid
vesicle shapes, a ﬁeld we have named vesicle origami.
■ VESICLE ORIGAMI
For simple geometric reasons, there are more phospholipid
molecules in the outer membrane leaﬂet than in the inner
membrane leaﬂet of a curved bilayer such as a vesicle. This
means that the area of the inner membrane is smaller than the
area of the outer membrane. Because the membrane cannot be
stretched, this diﬀerence in areas induces a bending of the
membrane into a curve.83
At room temperature, the two membrane leaﬂets of 1,3-
diamidophospholipid membranes are coupled by interdigita-
tion. The bending energy of such a stiﬀ membrane would be
too high to form a closed vesicle; therefore, vesicles are
formulated in a liquid-crystalline state above the main phase-
transition temperature of the membrane.36,84 Upon rapid
cooling to below Tm, the membranes reinterdigitate and
faceted vesicles form.22 Basically, the geometry induced by a
liquid-crystalline, deinterdigitated membrane has to be
changed to a gel-phase interdigitated membrane: the
membrane leaﬂets are connected, and the outer leaﬂet contains
more lipids than the inner leaﬂet. This has to lead to faceted
vesicles that contain membrane defects at the rim of the facets,
where the outer membrane is continuous and the inner leaﬂet
is broken (Figure 4).85 Similar faceted vesicles can be
formulated from many diﬀerent materials such as catanionic
amphiphiles86 and block copolymers.87 Essentially, the
membrane is then made from a ﬂexible rim and stiﬀ facets, a
multicomponent system that can adopt many geometries.88
Gel-phase phospholipid vesicles are faceted even when their
membranes are not fully interdigitated.89 Therefore, the
question arose as to if vesicle origami was also possible with
a phospholipid membrane that is not fully interdigitated. We
have resynthesized Pad-Pad-PC (2), a 1,2-diamidophospho-
lipid that was initially intended to be an anti-AIDS drug.90
Figure 4. (A) Spherical vesicles with a positive curvature C0 are
formed from nonconnected liquid-crystalline bilayer membrane
leaﬂets. (B) Interdigitated membranes are connected and must have
membrane defects (C) when forced into closed 3D geometries. The
lower row shows cryo-electron micrographs of extruded vesicles from
(D) pure Pad-PC-Pad and Pad-PC-Pad with (E) 10 and (F) 40 mol
% admixed cholesterol. The vesicles change from (D) rigid and
faceted to (F) highly ﬂexible. The scale bars are 200 nm, and the
white arrow points to an extremely faceted triangular vesicle.
Reprinted with permission from Tanasescu, R.; Lanz, M. A.; Mueller,
D.; Tassler, S.; Ishikawa, T.; Reiter, R.; Brezesinski, G.; Zumbuehl, A.
Vesicle Origami and the Inﬂuence of Cholesterol on Lipid Packing.
Langmuir 2016, 32, 4896−4903. Copyright 2016 American Chemical
Society.
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Similar to Sur-PC-Sur (11), Pad-Pad-PC (2) has strong
intermolecular hydrogen bonds, but because of the 1,2-
compared to the 1,3-tail arrangement, the molecules can
pack more tightly in the hydrogen-bond-deﬁned condensed
state.35 In fact, extremely tight subgel herringbone packing is
found, which leads to a very low area per lipid tail of 19 Å2.
The intramolecular hydrogen bonding is so strong that a wide-
angle X-ray scattering signal appears akin to the 4.75 Å repeat
distance seen between hydrogen-bonded peptide β-sheets.35,91
Pad-Pad-PC (2) forms an extremely stiﬀ bilayer and is forced
into a 3D assembly, where the vesicle maximizes its ﬂat
surfaces and minimizes its defect lines; the geometrical form
satisfying these constraints is a cube.35 Using vesicle origami,
we managed to formulate the ﬁrst free-standing, nontemplated
soft matter cuboid shortly after the ﬁrst DNA origami-
templated vesicle cube was reported.92
■ MECHANORESPONSIVE DRUG DELIVERY
Modern nanomedicine is currently suﬀering from a lack of
translation from in vitro experiments via in animal experiments
to in human medical applications. The translation of in vitro
work to in vivo work remains challenging and unpredictable.93
A recent review has unmistakably shown that tumor targeting
does not live up to its expectations in humans.94 Long-standing
facts such as passive targeting via the enhanced permeation and
retention (EPR) eﬀect turned out to be more heterogeneous in
humans than in optimized fast-growing xenografted mice
tumor models with dense vasculature.95 It has become clear
that once in contact with blood, a liposome is coated with a
dynamic corona, which changes the “biological identity” of the
liposome such as its size and aggregation state.96 Additionally,
the interaction between ions and headgroups can lead to
signiﬁcant physical changes on the liposomes, such as vesicle
fusion.97 Alternative, clever methods are being explored and
are entering clinical trials, such as the use of red blood cells as
drug delivery devices.98 At the same time, our understanding
grows as to how drug delivery actually works and how the
components of the blood, like leukocytes, may interfere with
the planned process.99
One decade ago, we began working on a collaborative
project in what is now called mechanoresponsive drug
delivery.100,101 Seeing the lack of eﬃciency of biological and
chemical drug targeting, we asked ourselves if it would be
possible to use physics, more speciﬁcally, shear forces to
disrupt bilayer vesicle membranes and to use such vesicles as
an alternative form of targeted drug delivery (Figure 5).102
The standard vesicles used for the delivery of hydrophobic
and hydrophilic drugs103 are in a liquid-crystalline phase;
therefore, they are in an energy-minimized spherical
conformation.104 Despite being self-assembled from individual
amphiphiles, vesicles are surprisingly resistant to lateral
membrane disruption. Calculations based on research reported
by Bernard et al. show that 100 nm liposomes formulated from
natural lipids and surfactants require shear stresses above 40 Pa
to disrupt their membranes.105 The wall shear stress in a
normal artery varies between 0.5 and 1.5 Pa and increases
signiﬁcantly by at least 1 order of magnitude at an arterial
constriction.106 This has the consequence that normal liquid-
crystalline vesicles cannot be used for mechanoresponsive drug
delivery. Gel-phase vesicles such as those made from Pad-PC-
Pad (5) and Rad-PC-Rad (6), on the other hand, are suited for
mechanoresponsive drug delivery. Our initial experiments
included vortex shaking of vesicles ﬁlled with 5(6)-carboxy-
ﬂuorescein. The liposomes were shaken on a vortex shaker at
2500 rpm for several seconds at diﬀerent temperatures (Figure
6). Mechanoresponsive cargo release can work only when the
vesicles are in the gel phase. Therefore, at a simulated body
temperature of 37 °C, Pad-PC-Pad vesicles (5, Tm = 37 °C)
fully release their cargo (Figure 6, right), whereas Rad-PC-Rad
vesicles (6, Tm = 44.7 °C) and DPPC vesicles (1, Tm = 42 °C)
remain active. The DPPC (1) vesicles, however, show only an
initial burst release and then remain tight for the rest of the
experiment.107
To translate this technology into clinics, an important
question to answer is whether the 1,3-diamidophospholipids
are toxic. The systemic administration of liposomes may trigger
a dangerous pseudoallergic reaction: an immediate activation
of the patient’s innate immune system.108 Surprisingly, our
initial screening in pigs showed only very mild activation of the
alternative pathway of the complement, a reaction also seen
with approved natural phospholipid liposome formulations.80
The low toxicity was also induced by the nonspherical shape:
Moghimi et al. have recently shown that spherically shaped
liposomes promote cardiopulmonary stress in pigs, and this
eﬀect can be mitigated by changing the shape to rods or
disks.109 The lack of toxicity is a promising factor for moving
the project forward.110,111
Interestingly, the concept of shear-sensitive drug delivery has
emerged at the same time in two diﬀerent laboratories divided
by the Atlantic Ocean, with Ingber et al. disclosing their
approach using drug-impregnated nanoparticle aggregates.112
In past years, more groups started to work on mechanores-
ponsive drug delivery.101 Grinstaﬀ et al. have deﬁned the ﬁeld
as harnessing “existing physiological and/or externally applied
forces to provide spatiotemporal control over the release of
active agents”.101 The ﬁeld is open for drug delivery systems
based on mechanical forces of compression, tension, and
shear101 and represents an attractive alternative to the classical
drug delivery routes. The most recent example of a shear-
sensitive liposomal system points to the bright future of an
exciting ﬁeld of research.113
■ SUMMARY
The chemical space of artiﬁcial phospholipids is vast, and most
molecules are awaiting their synthesis. In this article, only a
handful of new molecules were described. Nonetheless, the
biophysical properties of this limited choice were already
surprisingly rich. Soft matter phospholipid assemblies turned
out to be tunable and to adapt their shapes in reaction to
Figure 5. (A) Schematic depiction of the concept of mechanores-
ponsive drug delivery: special responsive vesicles release their cargo
upon passing through a region of elevated shear forces, such as a
constricted human artery. (B) Schematic depiction of the velocity
proﬁle of blood ﬂowing through idealized cylindrically shaped vessels.
At a constriction, the blood velocity and therefore also the wall shear
stress increase.102 Saxer, T.; Zumbuehl, A.; Müller, B. The Use of
Shear Stress for Targeted Drug Delivery. Cardiovasc. Res. 2013, 99,
328−333, used by permission of the European Society of Cardiology.
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mechanical stress,100 temperature change,22 and the addition
of cholesterol.79 Chemical synthesis of phospholipids is key to
exploring the frontiers of vesicle origami and going beyond
into applications of the concept in future personalized
medicine.
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assembly of different single-chain bolaphospholipids and their
miscibility with phospholipids or classical amphiphiles. Adv. Colloid
Interface Sci. 2014, 208, 264−278.
(57) Zaffalon, P. L.; D’Anna, V.; Hagemann, H.; Zumbuehl, A. Study
of surfactant alcohols with various chemical moieties at the
hydrophilic-hydrophobic interface. RSC Adv. 2013, 3, 7237−7244.
8
htt
p:/
/do
c.r
ero
.ch
(58) Stefaniu, C.; Zaffalon, P. L.; Carmine, A.; Verolet, Q.;
Fernandez, S.; Wesolowski, T. A.; Brezesinski, G.; Zumbuehl, A.
Rigid Urea and Self-Healing Thiourea Ethanlamine Monolayers.
Langmuir 2015, 31, 1296−1302.
(59) Zaffalon, P.-L.; Stalder, E.; Fedotenko, I. a.; Favarger, F.;
Zumbuehl, A. The synthesis of an amine-bearing polymerizable
phospholipid. Tetrahedron Lett. 2011, 52, 4215−4217.
(60) Schrettl, S.; Stefaniu, C.; Schwieger, C.; Pasche, G.; Oveisi, E.;
Fontana, Y.; Morral, A. F. I.; Reguera, J.; Petraglia, R.; Corminboeuf,
C.; Brezesinski, G.; Frauenrath, H. Functional carbon nanosheets
prepared from hexayne amphiphile monolayers at room temperature.
Nat. Chem. 2014, 6, 468−476.
(61) Giner-Casares, J. J.; Brezesinski, G.; Möhwald, H. Langmuir
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